Tag: asthma

July 22, 2017 Off

GSK submits EU filing for Relvar Ellipta extension

By Dino Mustafić

GlaxoSmithKline and Innoviva have asked the European Medicines Agency (EMA) to extend the use of  Relvar Ellipta, a once-daily fluticasone furoate/vilanterol-based (FF/VI) inhaled corticosteroid (ICS) / combination, in patients already adequately controlled on an ICS/LABA combination.

May 23, 2017 Off

Boehringer Ingelheim’s asthma drug test shows good results

By Dino Mustafić

Boehringer Ingelheim has reported new analyses that provide further evidence that adding SPIRIVA RESPIMAT improved breathing across diverse patient populations who experience uncontrolled asthma symptoms despite the use of another daily maintenance therapy in the Phase III clinical development program.

May 10, 2017 Off

AstraZeneca’s asthma drug study fails expectations

By Dino Mustafić

AstraZeneca and its subsidiary MedImmune have reported that tralokinumab, an anti-interleukin-13 (IL-13) human monoclonal antibody, did not meet its primary endpoint of a significant reduction in the annual asthma exacerbation rate (AAER) in the overall population of severe, uncontrolled asthma patients, compared with placebo in STRATOS 1, the first of two pivotal Phase III trials.